View Older Stories View More Recent Stories

Feb 25, 2014 04:05PM Speed Commerce to Present at the 26th Annual ROTH Conference on March 11, 2014

Feb 25, 2014 09:01AM SolarCity (SCTY) Q1 Outlook Constrained, But FY14 Deployment Outlook Kept in Check - Roth

Feb 25, 2014 08:30AM Edgewater to Present at the 26th Annual ROTH Conference on March 12, 2014

Feb 24, 2014 02:15PM Pharmacyclics' (PCYC) IMBRUVICA Drives Strong Q4 Results; Roth Boosts PT to $183

Feb 24, 2014 02:10PM Pharmacyclics (PCYC) PT Raised to $183 at Roth Capital

Feb 24, 2014 11:33AM Roth Reaffirms Curis (CRIS) at Buy; Erivedge, Internal Pipeline Both Ongoing Strengths

Feb 24, 2014 09:33AM Several Themes in Focus for SolarCity's (SCTY) Q4 Report; Upside Surprises Unlikely - Roth

Feb 24, 2014 09:00AM ZAGG Inc to Present at 26th Annual Roth Conference

Feb 20, 2014 07:04AM Roth Capital Downgrades Hecla Mining (HL) to Neutral

Feb 20, 2014 07:00AM Curis Reports Fourth Quarter and Year-End 2013 Financial Results

Feb 19, 2014 09:36AM Roth Eases Estimates on Enphase (ENPH) Following Q4 Results; Maintains 'Buy' Rating

Feb 19, 2014 08:22AM Roth Capital Downgrades Silvercrest Mines (SVLC) to Neutral

Feb 13, 2014 01:48PM Roth Lifts PT on Retrophin (RTRX) to $51; Impressive Manchester Pharma Purchase Will Bolster Business Plan

Feb 13, 2014 10:55AM Concert Pharmaceuticals (CNCE) IPO Jumps Higher

Feb 13, 2014 10:49AM Notable Analyst Rating Changes 02/13: (ANR) (ATHN) (NSPH) Upgraded; (DEPO) (REGN) (AEM) Downgraded

Feb 13, 2014 07:52AM Roth Capital Boosts PT on Pharmacyclics (PCYC) to $166; Strong IMBRUVICA Sales Ramp Expected

Feb 13, 2014 07:46AM Roth Capital Downgrades DepoMed Inc (DEPO) to Neutral

Feb 13, 2014 07:45AM Roth Capital Upgrades Nanosphere (NSPH) to Buy

Feb 12, 2014 08:43PM MacroGenics Announces Pricing of Public Offering of Common Stock

Feb 12, 2014 01:26PM Roth Keeps Regeneron (REGN) at 'Buy' Following Q4 Numbers, Outlook; VISTA, OUTLOOK Still in Focus

Feb 12, 2014 10:38AM Notable Analyst Rating Changes 02/12: (CROX) (S) (ZTS) Upgraded; (AMZN) (DF) (GMCR) Downgraded

Feb 12, 2014 09:35AM Pre-Open Stock Movers 2/12: (OC) (CSTE) (TRIP) Higher; (VTUS) (RLOC) (PRGN) Lower (more...)

Feb 12, 2014 08:13AM Roth Capital Starts Rally Software Development (RALY) at Buy

Feb 12, 2014 08:12AM Roth Capital Starts Orion Energy Systems (OESX) at Buy

Feb 12, 2014 07:23AM Roth Capital Lifts PT on Ligand (LGND) to $92; Still Sees Plenty of Positive Catalysts Ahead

Feb 12, 2014 07:04AM Canadian Solar (CSIQ) Prices 2.78M Common, $130M Convertible Notes Offering

Feb 11, 2014 06:50AM Roth Capital Downgrades Insperity (NSP) to Neutral

Feb 10, 2014 04:01PM MacroGenics Announces Proposed Public Offering of Common Stock

Feb 7, 2014 12:11PM Streetinsider.com's Hot Lunchtime Reads 02/07: (PG) (ANGI) (SODA) (PTEN)

Feb 7, 2014 11:01AM SodaStream (SODA)/ Pepsi (PEP) Deal is Unlikely, Says Roth Capital

Feb 6, 2014 05:38PM Pyramid Oil (PDO) and Yuma Enter Merger Pact

Feb 6, 2014 10:20AM Roth Capital Reaffirms Spectrum (SPPI) at Buy; FDA Grants Beleodaq NDA Priority Review

Feb 6, 2014 03:30AM Top Image Systems, Ltd. Closes $15.0 Million Public Offering of Ordinary Shares Including Exercise in Full of Overallotment Option

Feb 4, 2014 10:44AM Notable Analyst Rating Changes 02/04: (ZNGA) (MRK) (WETF) Upgraded; (HP) (NEM) (TTWO) Downgraded

Feb 4, 2014 08:06AM Roth Capital Starts Kindred Biosciences (KIN) at Buy

Feb 4, 2014 07:28AM Roth Capital Transfers Coverage/Upgrades Salesforce (CRM) to Buy

Feb 3, 2014 09:55AM Roth Keeps Ligand (LGND) at Buy; BD Indication for Promacta is Pleasant Surprise

Jan 31, 2014 09:05AM Top Image Systems, Ltd. Prices $13.1 Million Public Offering of Ordinary Shares

Jan 31, 2014 09:00AM Montage Technology Group Limited Announces Pricing of Follow-On Public Offering

Jan 30, 2014 06:08PM Top Image Systems (TISA) to Offer Common Stock

Jan 30, 2014 04:03PM Top Image Systems, Ltd. Announces Proposed Public Offering of Ordinary Shares

Jan 24, 2014 11:39AM Rexahn Pharma (RNN) Rises Back Above $1 Level with Volume

Jan 24, 2014 09:03AM Derma Sciences (DSCI) Prices 6.5M Offering at $11.50/Share

Jan 24, 2014 08:29AM Roth Capital Resumes GenVec (GNVC) at Buy; Novartis (NVS) Program Reinvigorates Excitement

Jan 24, 2014 08:21AM Tonix Pharma (TNXP) Prices 2.9M Common Offering at $15 Apiece

Jan 23, 2014 06:55AM Keryx Biopharma (KERX) Prices 6.9M Offering at $14.50/Share

Jan 21, 2014 09:33AM Roth Capital Boosts PT on Keryx Biopharma (KERX) to $30 Following Ferric Citrate Approval in Japan

Jan 21, 2014 06:50AM Roth Capital Starts BioCryst Pharma (BCRX) at Buy

Jan 17, 2014 09:14AM Roth Capital Starts Paramount Gold and Silver (PZG) at Buy

Jan 16, 2014 09:13AM Dendreon (DNDN) Updates Outlook, But Concerns with Provenge Remain; Roth Reiterates 'Sell"

View More Recent Stories View Older Stories